| Literature DB >> 27279857 |
Magdalena M Woźniak1, Thomas M Scholbach2, Jakob Scholbach3, Agata Pawelec1, Paweł Nachulewicz4, Andrzej P Wieczorek1, Agnieszka Brodzisz1, Maria M Zajączkowska5, Halina Borzęcka5.
Abstract
INTRODUCTION: Vesicoureteral reflux (VUR) occurs in 20-50% of children suffering from recurrent urinary tract infections (UTIs) and is associated with an increased risk of renal scarring and impaired renal function. Early detection of renal perfusion deterioration would allow for the implementation of more aggressive treatment and potentially prevent further damage to the renal parenchyma. The aim of the study was to assess renal parenchymal perfusions in children with recurrent UTIs with and without coexisting VUR, and compare the findings with the results of healthy patients.Entities:
Keywords: PixelFlux; renal parenchymal perfusion; urinary tract infections; vesicoureteral reflux
Year: 2015 PMID: 27279857 PMCID: PMC4889678 DOI: 10.5114/aoms.2015.51698
Source DB: PubMed Journal: Arch Med Sci ISSN: 1734-1922 Impact factor: 3.318
Figure 1Illustration of signal quantification in a kidney with PixelFlux. Top left – color Doppler – the first frame of a video sequence with a parallelogram placed between the outer border of the medullary pyramids and the renal surface. Three diagrams showing changes in relevant perfusion parameters: red lines refer to red color Doppler pixels, blue lines to blue pixels. Top right – changes in perfused area; bottom left – changes in mean flow intensity; bottom right – changes in mean flow velocity
Mean values of perfusion parameters in study groups 1 and 2 and the control group. Cortical parenchymal perfusion of children from study group 1 (suffering from urinary tract infections (UTIs) and vesicoureteral reflux (VUR)) was significantly reduced relative to the control group of healthy children in all measured parameters. No significant differences in parenchymal perfusion were found between study group 2 (children suffering solely from recurrent UTIs) and the control group for any of the measured perfusion parameters
| Variable | |||||
|---|---|---|---|---|---|
| Study group 1 (UTIs + VUR) | 3.5641 | 0.2705 | 0.5632 | 0.6488 | 1.1929 |
| Study group 2 (UTIs) | 4.0704 | 0.3469 | 0.7326 | 0.5425 | 0.8222 |
| Control group | 4.1955 | 0.3360 | 0.7088 | 0.5235 | 0.7970 |
Statistical difference vs. control group at p < 0.05.
Figure 2Mean values of v in study group 1 (UTIs and VUR) according to VUR grade/control group. No significant difference between control group and VUR grade II, significant differences between control group and VUR grades III and IV
Figure 4Mean values of I in study group 1 (UTIs and VUR) according to VUR grade/control group. No significant difference between control group and VUR grade II, significant differences between control group and VUR grades III and IV
Mean values of perfusion parameters in study group 1 (suffering from urinary tract infections (UTIs) and vesicoureteral reflux (VUR)) according to VUR grade/control group. There was no significant difference in renal parenchymal perfusion between the control group and VUR grade II, whereas there were significant differences between the control group and VUR grades III and IV in almost all measured perfusion parameters
| Variable | |||||
|---|---|---|---|---|---|
| Control group | 4.1955 | 0.3360 | 0.7088 | 0.5235 | 0.7970 |
| VUR grade II | 4.1705 | 0.3585 | 0.7908 | 0.5487 | 1.0921 |
| VUR grade III | 3.5580 | 0.2432 | 0.4824 | 0.5939 | 1.1122 |
| VUR grade IV | 2.4114 | 0.1667 | 0.3052 | 0.9381 | 1.4252 |
Significant difference vs. control group at p < 0.05.